A detailed history of Ameriprise Financial Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 64,912 shares of IDYA stock, worth $2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,912
Previous 213,514 69.6%
Holding current value
$2 Million
Previous $9.37 Million 75.67%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$34.37 - $43.46 $5.11 Million - $6.46 Million
-148,602 Reduced 69.6%
64,912 $2.28 Million
Q1 2024

May 15, 2024

SELL
$34.2 - $47.13 $363,443 - $500,850
-10,627 Reduced 4.74%
213,514 $9.37 Million
Q4 2023

Feb 14, 2024

SELL
$24.59 - $35.83 $1.21 Million - $1.77 Million
-49,332 Reduced 18.04%
224,141 $7.97 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $659,743 - $932,158
31,312 Added 12.93%
273,473 $7.38 Million
Q2 2023

Aug 14, 2023

SELL
$13.33 - $25.53 $2.55 Million - $4.89 Million
-191,521 Reduced 44.16%
242,161 $5.69 Million
Q1 2023

May 15, 2023

BUY
$13.49 - $18.72 $311,780 - $432,656
23,112 Added 5.63%
433,682 $5.95 Million
Q4 2022

Feb 14, 2023

BUY
$14.47 - $18.17 $5.04 Million - $6.32 Million
348,005 Added 556.23%
410,570 $7.46 Million
Q3 2022

Nov 14, 2022

SELL
$9.24 - $15.79 $17,676 - $30,206
-1,913 Reduced 2.97%
62,565 $933,000
Q2 2022

Aug 15, 2022

BUY
$8.28 - $13.88 $24,318 - $40,765
2,937 Added 4.77%
64,478 $889,000
Q1 2022

May 16, 2022

SELL
$11.18 - $24.02 $23,478 - $50,442
-2,100 Reduced 3.3%
61,541 $688,000
Q4 2021

Feb 14, 2022

BUY
$20.95 - $26.88 $1.01 Million - $1.3 Million
48,421 Added 318.14%
63,641 $1.51 Million
Q4 2020

Feb 12, 2021

BUY
$12.17 - $17.52 $1,338 - $1,927
110 Added 0.73%
15,220 $213,000
Q3 2020

Nov 16, 2020

BUY
$11.22 - $14.46 $169,534 - $218,490
15,110 New
15,110 $190,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.48B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.